Medicrea International S.A.S. (Medtronic)

Rillieux-la-Pape, France  All France companies → — Founded 1990
Healthcare Conglomerate Medical Device / Hardware Specialty-Focused AI
Neurosurgery Orthopedics
Surgical AI
Acquired — €140 million (acquisition value by Medtronic)
Claim this company

Products

UNiD™ Spine Analyzer
Medicrea International S.A.S. (Medtronic)
Surgical AI
The UNiD™ Spine Analyzer is an AI-powered platform by Medtronic (formerly Medicrea) for personalized spine surgery planning, predictive modeling, and patient-specific implants for spinal deformities and degenerative conditions.
Contact for pricing

See all 1 product →

About Medicrea International S.A.S. (Medtronic)

Medicrea International S.A.S. was a pioneering French company focused on transforming spinal surgery through artificial intelligence (AI), predictive modeling, and patient-specific implants. Their flagship UNiD™ ASI (Adaptive Spine Intelligence) platform leveraged a database of over 6,000 surgical cases. This platform utilized sophisticated algorithms to visualize multiple permutations, enabling surgeons to precisely understand a patient’s spinal alignment pre-operatively, customize surgical plans, and design personalized spinal rods.

The company’s product portfolio included over 30 FDA-cleared or CE-marked implant technologies, specifically designed for various spinal pathologies such as adult deformity, pediatric deformity, and degenerative disease. Medicrea’s approach aimed to enhance the efficiency of spinal care, reduce surgical complications, and improve long-term patient outcomes by providing highly tailored solutions. Medtronic acquired Medicrea in November 2020 to integrate these advanced AI-driven surgical planning capabilities, personalized spinal implants, and robotic-assisted surgery into its offerings, aiming to provide a comprehensive, integrated solution for spine care.

Focus Areas

Spinal surgery Artificial Intelligence Predictive Modeling Patient-Specific Implants 3D-Printed Titanium Implants Sagittal Balance Adult Spinal Deformity Pediatric Spinal Deformity Degenerative Spinal Disease

Business Intelligence

Key InvestorsAthyrium Capital Management, M Capital Partners, Odyssee Venture, Trail (Paris), iXO Private Equity
PartnershipsMedicrea Australia (Joint Venture)
AcquisitionsAcquired by Medtronic plc on November 16, 2020
TechnologyUNiD™ ASI (Adaptive Spine Intelligence) platform, UNiD™ HUB, UNiD™ Spine Analyzer Software, proprietary predictive models, AI, Machine Learning, Big Data, 3D Printing
FDA Clearances30+ cleared products (estimated)

What Physicians Need to Know

Spinal Surgery Specialization
Medicrea International S.A.S. (now part of Medtronic) specializes in comprehensive spinal surgery, addressing complex pathologies including Adult Spinal Deformity, Pediatric Spinal Deformity, and Degenerative Spinal Disease. Their offerings encompass a wide range of implant technologies (over 30 510(k) cleared or CE Mark approved) used in various surgical techniques, including minimally-invasive surgery.
Artificial Intelligence & Predictive Modeling
A core specialization is the deployment of Artificial Intelligence (AI) and predictive modeling to transform spinal surgery. Their UNiDu2122 ASI (Adaptive Spine Intelligence) platform leverages a database of over 10,000 surgical cases to power algorithms that visualize multiple permutations, simulate surgical approaches, and predict patient responses to surgery.
Patient-Specific & 3D-Printed Implants
The company is a pioneer in patient-specific implants, including custom-designed interbody cages and industrially pre-bent, 3D-printed titanium rods. These implants are precisely tailored to each patient's anatomy and the AI-driven pre-operative surgical plan to achieve optimal sagittal balance and alignment.
Key Differentiator: Integrated AI Solution
Medtronic, through Medicrea, is the first company to offer an integrated solution that combines AI-driven surgical planning, personalized spinal implants, and robotic-assisted surgical delivery. This comprehensive approach aims to redefine spine procedures by reducing variability and improving outcomes.
Technology Stack: UNiDu2122 ASI Platform
The flagship technology is the UNiDu2122 ASI (Adaptive Spine Intelligence) platform. This software solution integrates predictive modeling and sophisticated algorithms to measure and digitally reconstruct a patient's spine to its optimal profile. It supports surgeon workflow in pre-operative planning and facilitates the creation of personalized implant solutions.
Physician Tip

For physicians, Medicrea International S.A.S. (Medtronic) offers 'augmented intelligence' by integrating machine intelligence into all aspects of the care pathway, from planning to delivery. This translates to more tailored and personalized patient care, with the goal of reducing surgical variability and improving long-term outcomes. The UNiDu2122 ASI platform provides data-driven insights and predictive capabilities, allowing for precise pre-operative planning, simulation of multiple approaches, and the use of patient-specific implants (like pre-bent rods and custom cages) to achieve optimal spinal alignment. This can lead to safer procedures and more reliable outcomes, potentially preventing costly revision surgeries.

Medicrea's technologies are fully integrated into Medtronic's broader portfolio of spine implants, robotics (e.g., Mazor X), navigation (e.g., Stealth Station Navigation), and 3D imaging technology. This creates a seamless, fully-integrated procedural solution for surgical planning and delivery, enhancing Medtronic's overall capabilities in spine care.

Products by Medicrea International S.A.S. (Medtronic)

1 product in the directory

UNiD™ Spine Analyzer
Medicrea International S.A.S. (Medtronic)
Surgical AI
The UNiD™ Spine Analyzer is an AI-powered platform by Medtronic (formerly Medicrea) for personalized spine surgery planning, predictive modeling, and patient-specific implants for spinal deformities and degenerative conditions.
Contact for pricing

What the Web Says

Medicrea International S.A.S., now part of Medtronic, generally receives mixed to positive reviews. While their product, UNiD ASI, is often praised for its innovative AI-driven surgical planning and personalized implants, the company's employer reviews, particularly pre-acquisition, indicate some challenges with management and work-life balance, though post-acquisition sentiment is less clear.

Overall: Mixed

Strengths

  • Innovative AI-driven surgical planning (UNiD ASI)
  • Personalized implants for improved patient outcomes
  • Strong focus on technology and R&D
  • Potential for career growth within Medtronic (post-acquisition)
  • Positive impact on patient care
  • Good product support and training for surgeons

Limitations

  • Pre-acquisition management issues reported
  • Challenges with work-life balance (pre-acquisition)
  • Integration complexities post-acquisition with Medtronic
  • Limited independent reviews post-acquisition specifically for Medicrea as a standalone entity
  • Compensation concerns mentioned in older employer reviews
  • Bureaucracy within a large organization like Medtronic

Based on reviews from: Glassdoor, G2, Capterra, Reddit, Healthcare IT News (general industry articles mentioning UNiD ASI)

Last updated: 2026-07-18

Videos

News, demos, and interviews about Medicrea International S.A.S. (Medtronic).

Loading videos...

Videos load interactively. If none appear, search YouTube for Medicrea International S.A.S. (Medtronic) →

View all on YouTube

Press & Coverage

Medical Device Network
Medtronic acquires French spinal implant maker Medicrea
Medtronic completed its acquisition of Medicrea International in November 2020, expanding its AI and data capabilities to offer an integrated spine solution with AI-driven surgical planning, personalized spinal implants, and robotic-assisted surgery. This acquisition was Medtronic's seventh in 2020.
2020-11
Medtronic News Center
Medtronic Completes Acquisition of Medicrea
Medtronic announced the completion of its friendly tender offer for Medicrea International, a pioneer in AI, predictive modeling, and patient-specific spinal implants. The acquisition makes Medicrea a wholly-owned subsidiary of Medtronic and enhances Medtronic's offerings in personalized implants and AI-driven planning.
2020-11
Fierce Biotech
Medtronic to Acquire Medicrea, maker of patient-specific, 3D-printed spine implants
In July 2020, Medtronic announced its intent to acquire Medicrea, a French developer of patient-specific, 3D-printed titanium spinal implants, for u20ac7 per share. This move aimed to integrate AI-driven surgical planning, personalized implants, and robotic-assisted surgery into Medtronic's spine solutions.
2020-07
Guided Solutions
Medtronic expands spinal surgery capabilities with Medicrea acquisition
Medtronic's acquisition of Medicrea International allows it to offer an integrated spine solution that includes AI-driven surgical planning, personalized spinal implants, and robotic-assisted surgery. This transaction was Medtronic's seventh acquisition in 2020, bolstering its AI and machine learning capabilities.
2020-11
VoxelMatters
Medtronic to acquire French spinal implant developer Medicrea | VoxelMatters
Medtronic announced its plan to acquire Medicrea, a French company specializing in AI and predictive modeling for patient-specific spinal implants, in July 2020. The acquisition aimed to combine Medtronic's existing spinal technology with Medicrea's AI-driven custom implants and 3D printing capabilities.
2020-07
DeviceTalks
How Medicrea's personalized implants and AI will drive Medtronic's cranial and spine business | DeviceTalks
An article from March 2022 discusses how Medicrea's personalized implants and AI applications are driving Medtronic's cranial and spine business. It highlights the integration of AI and predictive modeling into spine surgery, along with patient-specific implants.
2022-03
accessdata.fda.gov
Medicrea International S.A.S. (Medtronic) Cecile Humbert Sr Regulatory Affairs Specialist 5389 Route de Strasbourg - accessdata.fda.gov
A regulatory announcement from August 2025 indicates that Medicrea International S.A.S. (Medtronic) received 510(k) premarket notification clearance for its UNiDu2122 Spine Analyzer. This device assists healthcare professionals in viewing, measuring images, and planning orthopedic surgeries, including the design of patient-specific implants.
2025-08
accessdata.fda.gov
December 19, 2025 Medicrea International S.A.S. (Medtronic) Gautier Liegeon Senior Regulatory Affairs Specialist 5389 Route De S
An FDA 510(k) premarket notification from December 2025 shows clearance for Medicrea International S.A.S. (Medtronic)'s IB3Du2122 PL Spinal System. This device is intended for intervertebral body fusion in patients with degenerative disc disease.
2025-12

Frequently Asked Questions

Medtronic's acquisition of Medicrea significantly expanded its spinal surgery capabilities by integrating Medicrea's UNiDu2122 Adaptive Spine Intelligence (ASI) platform. This platform leverages AI and predictive modeling, drawing on a database of thousands of surgical cases, to help surgeons develop patient-specific surgical plans and digitally reconstruct the spine to its optimal profile. This integration aims to reduce surgical variability and improve patient outcomes across adult and pediatric spinal deformities, and degenerative spinal disease.
The Medtronic portfolio, enhanced by Medicrea's technology, offers patient-specific 3D-printed titanium interbody cages and personalized rods. These implants are custom-designed to fit a patient's unique anatomy, allowing for precise correction of spinal curves and optimizing contact between the implant and vertebrae. Medicrea had over 30 FDA-cleared implant technologies, including specialized components for pediatric spinal deformities.
The UNiD ASI platform is designed to address these complex conditions by enabling surgeons to create personalized surgical plans that restore optimal sagittal balance and correct deformities. By utilizing predictive modeling and patient-specific implants, the technology helps achieve precise alignment objectives for adult and pediatric spinal deformities, and degenerative spinal disease. This approach aims to improve long-term patient quality of life by restoring the spine's natural profile.
As a wholly-owned subsidiary of Medtronic, Medicrea's products and operations now fall under Medtronic's comprehensive compliance and regulatory framework. Medtronic maintains robust compliance guidelines for its business partners and products, including adherence to FDA clearances and CE Mark approvals. The company is committed to ethical practices and transparent reporting, as evidenced by its participation in programs like the Open Payments Program.
Physicians and healthcare administrators can expect comprehensive support from Medtronic, leveraging its global infrastructure for training, technical assistance, and clinical education. The integration of Medicrea's UNiD ASI platform into Medtronic's AiBLEu2122 ecosystem further enhances this, combining AI-driven planning with robotic-assisted surgery and advanced imaging. Medtronic also collaborates with industry bodies like AdvaMed to ensure high standards of distributor compliance and support.
Medicrea is now a wholly-owned subsidiary of Medtronic, a global leader in medical technology, ensuring strong company stability and continuity for its innovative spinal solutions. Medtronic views Medicrea's AI and personalized implant capabilities as a strategic expansion, integrating them into its broader spine surgery portfolio to drive future advancements. This integration positions Medtronic as a leader in individualized patient care in spinal surgery.

Related Companies

CAIMed (Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin)
Hannover, Germany (Lower Saxony region)

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm
Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA
London, UK

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
London, United Kingdom

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI
Canberra, ACT, Australia

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART
Boizenburg / Elbe, Germany

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.